[Efficacy of recombinant activated factor VII for treatment of life-threatening bleeding in cardiac surgery]

MeSH terms

• Aged
• Anticoagulants / administration & dosage
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use
• Antifibrinolytic Agents / administration & dosage
• Antifibrinolytic Agents / therapeutic use
• Aortic Valve / surgery
• Aspirin / adverse effects
• Aspirin / therapeutic use
• Blood Component Transfusion
• Blood Loss, Surgical*
• Clopidogrel
• Endocarditis, Bacterial / surgery
• Enoxaparin / administration & dosage
• Enoxaparin / adverse effects
• Enoxaparin / therapeutic use
• Factor VII / therapeutic use*
• Factor VIIa
• Heart Valve Prosthesis Implantation*
• Heparin / administration & dosage
• Heparin / adverse effects
• Heparin / therapeutic use
• Humans
• Male
• Norepinephrine / therapeutic use
• Platelet Aggregation Inhibitors / administration & dosage
• Platelet Aggregation Inhibitors / adverse effects
• Platelet Aggregation Inhibitors / therapeutic use
• Preanesthetic Medication
• Recombinant Proteins / therapeutic use
• Shock / drug therapy
• Staphylococcal Infections / surgery
• Ticlopidine / administration & dosage
• Ticlopidine / analogs & derivatives
• Ticlopidine / therapeutic use
• Tranexamic Acid / administration & dosage
• Tranexamic Acid / therapeutic use